Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INICOM: Gemigliptin plus metformin versus monotherapy in type 2 diabetes mellitus
TCTR20191213002Phase 3Completed
- Sponsor
- LG Chem
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemigliptin, metformin in type 2 diabetes mellitus (T2DM), sponsored by LG Chem. Started Jan 2013; status: completed.
02
Drugs
gemigliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20191213002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191213002.